Arbutus Biopharma : AB‐729, a GalNAc‐siRNA, results in robust reductions of HBV DNA and ...

Retrieved on: 2021-02-08 09:22:30

Tags for this article:

Click the tags to see associated articles and topics

Arbutus Biopharma : AB‐729, a GalNAc‐siRNA, results in robust reductions of HBV DNA and .... View article details on hiswai:

Excerpt

Arbutus Biopharma : AB‐729, a GalNAc‐siRNA, results in robust reductions of HBV DNA and HBsAg in subjects with chronic hepatitis B infection ...

Article found on: www.marketscreener.com